Dana N. Raugi

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants”.

Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac037

N/A

0.330DataRank · unranked

8 citations

Vincent H. Wu, Jennifer Song, Dana N. Raugi, Khardiata Diallo Mbaye, Moussa Seydi +2 more

Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal

Trials(2021)10.1186/s13063-021-05902-5

N/A

0.208DataRank · unranked

3 citations

Khardiata Diallo, Mouhamadou Baïla Diallo, Dominique Faye, Ousseynou Cisse, Robert A. Smith +11 more

Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232

PLoS ONE(2023)10.1371/journal.pone.0280568

N/A

0.208DataRank · unranked

3 citations

Dana N. Raugi, Robert S. Nixon, Jennifer Song, Moussa Seydi, Geoffrey S. Gottlieb +1 more

HIV-2 Drug Resistance Genotyping from Dried Blood Spots

Journal of Clinical Microbiology(2020)10.1128/jcm.02303-20

N/A

0DataRank · unranked

6 citations

Robert S. Nixon, Sally Leong, Khadim Faye, Jean Phillipe Diatta, Fatima Sall +6 more

Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa

Clinical Infectious Diseases(2020)10.1093/cid/ciaa277

N/A

0DataRank · unranked

15 citations

Selly Ba, Ousseynou Cisse, Khardiata Diallo, Ibrahima Tito Tamba, Cheikh Tidiane Ndour +64 more

Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad562

N/A

0DataRank · unranked

16 citations

Dana N. Raugi, Robert S. Nixon, Moussa Seydi, Nicolas Margot, Christian Callebaut +43 more

Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa026

N/A

0DataRank · unranked

26 citations

Diane Descamps, Soo‐Yon Rhee, Dana N. Raugi, Charlotte Charpentier, Nuno Taveira +7 more